EUVIMEDEUVIMED entdecken
Crossref

Ruthenium Oxide Nanozyme for Tendinopathy Treatment via Countering Ferroptosis

Chenfeng Qiao, Ziying Sun, Faheem Muhammad, Wenli Gong, Jintao Lin, Jie Lv, Xi Cheng, Yuxiang Fei, Nuo Xu, Ya Xie, Ruiyang Jiang, Chenguang Lin und 14 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202501035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Chenfeng Qiao und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210002, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Tendinopathy, Ruthenium, Ruthenium Compounds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Scientific Research Project of Jiangsu Commission of Health, Jiangsu Funding Program for Excellent Postdoctoral Talent, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global prevalence of tendinopathy (TP) is steadily increasing, resulting in functional impairments in tendons across individuals of all ages. Excessive accumulation of reactive oxygen species (ROS) plays a pivotal role in the development of TP, which compromises tendon repair and integrity through oxidative stress. This process is often accompanied by ferroptosis—a newly recognized form of iron‐dependent programmed cell death. This study explores ruthenium oxide (RuO 2 ) hollow nanospheres as an effective nanozyme to address oxidative damage and ferroptosis in type I collagenase‐induced TP. In vitro experiments show decreased mRNA levels of inflammatory biomarkers in tenocytes, while western blot analysis and immunofluorescence reveal reduced extracellular matrix degradation after RuO 2 treatment. In the TP model, the RuO 2 nanozyme therapy and improves tendon fiber arrangement, alleviates pain, and increases type I collagen expression while preventing matrix degradation. These findings suggest that the RuO 2 nanozyme possesses significant antioxidant and anti‐inflammatory properties, providing protective effects on tenocytes by ROS scavenging and countering ferroptosis, indicating its potential for treating TP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisTendinopathyRutheniumRuthenium CompoundsAnimalsReactive Oxygen SpeciesTenocytesMaleMiceOxidative Stress

Stichwörter der Autor:innen

antioxidant nanozymeferroptosisreactive oxygen speciesruthenium oxidetendinopathy

Substanzen

Reactive Oxygen SpeciesRutheniumRuthenium Compounds

Autor:innen und Institutionen

  • Department of Orthopedics, Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210002, P. R. China.
  • Department of Orthopedics, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210002, P. R. China.
  • Guangdong Key Laboratory of Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, P. R. China.
  • Department of Biomedical Engineering, College of Engineering and Applied Sciences, Nanjing National Laboratory of Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing,…
  • Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, P. R. Chi…
  • Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210008, P. R. Chi…

ORCID-Profile: Hui Wei

Förderung

  • Scientific Research Project of Jiangsu Commission of Health
  • Jiangsu Funding Program for Excellent Postdoctoral Talent
  • China Postdoctoral Science Foundation
  • National Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Qiao, C., Sun, Z., Muhammad, F., Gong, W., Lin, J., Lv, J., Cheng, X., Fei, Y., Xu, N., Xie, Y., Jiang, R., Lin, C., Yang, H., Lv, Z., Wang, Z., Liu, Y., Lu, Z., Gu, X., Zhang, Z., …, & Bao, N. (2025). Ruthenium Oxide Nanozyme for Tendinopathy Treatment via Countering Ferroptosis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501035

Vancouver

Qiao C, Sun Z, Muhammad F, Gong W, Lin J, Lv J, et al. Ruthenium Oxide Nanozyme for Tendinopathy Treatment via Countering Ferroptosis. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202501035

BibTeX
@article{Qiao2025,
  author = {Qiao, Chenfeng and Sun, Ziying and Muhammad, Faheem and Gong, Wenli and Lin, Jintao and Lv, Jie and Cheng, Xi and Fei, Yuxiang and Xu, Nuo and Xie, Ya and Jiang, Ruiyang and Lin, Chenguang and Yang, Haoyu and Lv, Zhongyang and Wang, Zheng and Liu, Yuan and Lu, Zhihao and Gu, Xiang and Zhang, Zhaofeng and Hu, Chunqing and Zhang, Hanwen and Meng, Jia and Yang, Xiaojiang and Shi, Dongquan and Wei, Hui and Bao, Nirong},
  title = {Ruthenium Oxide Nanozyme for Tendinopathy Treatment via Countering Ferroptosis},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202501035}
}
Kostenlos starten →